Michael Midler, Jr. is a notable inventor based in East Brunswick, NJ (US). He has made significant contributions to the fields of crystallization and emulsion technologies. With a total of 3 patents, his work has had a considerable impact on various applications in the pharmaceutical and chemical industries.

Latest Patents

Midler's latest patents include a crystallization method designed to improve crystal structure and size. This innovative process utilizes impinging fluid jet streams in a continuous crystallization process to achieve high-intensity micromixing of fluids. This method allows for the direct crystallization of high surface area particles that exhibit high purity and stability. Another significant patent is a process for preparing a highly stable water-in-oil type emulsion. This emulsion consists of a disperse aqueous phase and a continuous oil phase containing isomannide monooleate emulsifier and a non-hydrated physiologically acceptable fatty acid metal salt. A particular application of this invention is in the preparation of an emulsion adjuvant vaccine, where the vaccine is incorporated in the aqueous phase.

Career Highlights

Michael Midler, Jr. is currently employed at Merck & Co., Inc., a leading global healthcare company. His work at Merck has allowed him to further develop his innovative ideas and contribute to the advancement of medical and pharmaceutical technologies.

Collaborations

Throughout his career, Midler has collaborated with esteemed colleagues, including Edward L. Paul and Edwin F. Whittington. These collaborations have fostered a productive environment for innovation and have led to the successful development of his patented technologies.

Conclusion

Michael Midler, Jr. is a distinguished inventor whose work in crystallization and emulsion technologies has made a significant impact in his field. His contributions continue to influence advancements in pharmaceutical applications and beyond.